Augusto César Parreiras de Jesus

Dr. Augusto César Parreiras de Jesus

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2024 in BMC Medicine
Verified
Journal Article
Open access
PDF file
AJAugusto César Parreiras de Jesus
Augusto César Parreiras de Jesus
Paula FonsecaPaula Fonseca
Paula Fonseca
Hugo Jose AlvesHugo Jose Alves
Hugo Jose Alves
DBDiego Menezes Bonfim
Diego Menezes Bonfim
JDJoão Victor Rodrigues Dutra
João Victor Rodrigues Dutra
RARenato Aguiar
Renato Aguiar
The rapid spread and increase of chikungunya (CHIKV) and dengue (DENV) cases in Brazilian regions in 2023 has raised concerns about the impact of arboviruses on public health. Epidemiological and genomic surveillance was performed to estimate the introduction and spread of CHIKV and DENV in Brazil. This study obtained results from the Hermes Pardini (HP), a private medical laboratory, and the Health Department of Minas Gerais state (SES-MG). We investigated the positivity rates of CHIKV and DENV by analyzing the results of 139,457 samples tested for CHIKV (44,029 in 2022 and 95,428 in 2023) and 491,528 samples tested for DENV (163,674 in 2022 and 327,854 in 2023) across the five representative geographical regions of Brazil. Genome sequencing was performed on 80 CHIKV and 153 DENV samples that had been positive for RT-PCR tests. In our sampling, the data from CHIKV tests indicated that the Northeast region had the highest regional positivity rate in 2022 (58.1%). However, in 2023, the Southeast region recorded the highest positivity rate (40.5%). With regard to DENV, the South region exhibited the highest regional positivity rate in both 2022 (40.8%) and 2023 (22.7%), followed by the Southeast region in both years (34.8% in 2022; 21.4% in 2023). During the first 30 epidemiological weeks of 2023 in the state of Minas Gerais (MG), there was a 5.8-fold increase in CHIKV cases and a 3.5-fold increase in DENV compared to the same period in 2022. Analysis of 151 new DENV-1 and 80 CHIKV genomes revealed the presence of three main clusters of CHIKV and circulation of several DENV lineages in MG. All CHIKV clades are closely related to genomes from previous Brazilian outbreaks in the Northeast, suggesting importation events from this region to MG. We detected the RNA of both viruses in approximately 12.75% of the confirmed positive cases, suggesting an increase of co-infection with DENV and CHIKV during the period of analysis. These high rates of re-emergence and co-infection with both arboviruses provide useful data for implementing control measures of Aedes vectors and the urgent implementation of public health politics to reduce the numbers of CHIKV and DENV cases in the country.

1 October 2020 in Microbial Pathogenesis
Verified
Journal Article
Closed access
AOAna Laura Grossi de Oliveira
Ana Laura Grossi de Oliveira
ACAna Thereza Chaves
Ana Thereza Chaves
MCMariana Santos Cardoso
Mariana Santos Cardoso
GPGuilherme Rafael Gomide Pinheiro
Guilherme Rafael Gomide Pinheiro
AJAugusto César Parreiras de Jesus
Augusto César Parreiras de Jesus
CMCristiane Alves da Silva Menezes
Cristiane Alves da Silva Menezes

16 January 2025 in ACS Sensors
Verified
Journal Article
Open access
RCRocio Arreguin Campos
Rocio Arreguin Campos
RBRamayana Morais de Medeiros Brito
Ramayana Morais de Medeiros Brito
APAna Rafaela Antunes Porto
Ana Rafaela Antunes Porto
AJAugusto César Parreiras de Jesus
Augusto César Parreiras de Jesus
LBLilian Lacerda Bueno
Lilian Lacerda Bueno
BGBart Van Grinsven
Bart Van Grinsven
Malaria is a major public healthcare concern worldwide, representing a leading cause of death in specific regions. The gold standard for diagnosis is microscopic analysis, but this requires a laboratory setting, trained staff, and infrastructure and is therefore typically slow and dependent on the experience of the technician. This study introduces, for the first time, a biomimetic sensing platform for the direct detection of the disease. The heart of the sensor consists of a synthetic receptor created by surface imprinting Plasmodium falciparum-infected erythrocytes in a polymeric matrix. This receptor layer is coupled to a low-cost and fast thermal transducer platform, allowing for real time detection of the infection. The artificial receptor is a composite of poly(dimethylsiloxane) and graphene oxide that, in combination with the thermal readout, exhibited a limit of detection below 0.5% parasitemia in erythrocyte samples. This value is relevant for the diagnosis of infection in patients with low parasitemia levels. This study proves that biomimetic sensors could be further explored for the development of point-of-care technologies for the management of the disease.

1 November 2020 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
AJAugusto César Parreiras de Jesus
Augusto César Parreiras de Jesus
AOAna Laura Grossi de Oliveira
Ana Laura Grossi de Oliveira
NGNathalia Sernizon Guimarães
Nathalia Sernizon Guimarães
LMLeonel Mendoza
Leonel Mendoza
RFRicardo Fujiwara
Ricardo Fujiwara
RVRaquel Virginia Rocha Vilela
Raquel Virginia Rocha Vilela

23 September 2024 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
FCFelipe Campelo
Felipe Campelo
AOAna Laura Grossi de Oliveira
Ana Laura Grossi de Oliveira
JRJoão Reis-Cunha
João Reis-Cunha
VFVanessa Gomes Fraga
Vanessa Gomes Fraga
PSPedro Henrique Bastos e Silva
Pedro Henrique Bastos e Silva
FLFrancisco Pereira Lobo
Francisco Pereira Lobo
We introduce a phylogeny-aware framework for predicting linear B-cell epitope (LBCE)-containing regions within proteins. Our approach leverages evolutionary information by using a taxonomic scaffold to build models trained on hierarchically structured data. The resulting models present performance equivalent or superior to generalist methods, despite using simpler features and a fraction of the data volume required by current state-of-the-art predictors. This allows the utilization of available data for major pathogen lineages to facilitate the prediction of LBCEs for emerging infectious agents. We demonstrate the efficacy of our approach by predicting new LBCEs in the monkeypox (MPXV) and vaccinia viruses. Experimental validation of selected targets using sera from infected patients confirms the presence of LBCEs, including candidates for the differential serodiagnosis of recent MPXV infections. These results point to the use of phylogeny-aware predictors as a useful strategy to facilitate the targeted development of immunodiagnostic tools.

5 March 2025 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
AJAugusto César Parreiras de Jesus
Augusto César Parreiras de Jesus
VFVanêssa Gomes Fraga
Vanêssa Gomes Fraga
SPSamuel Alexandre Pimenta-Carvalho
Samuel Alexandre Pimenta-Carvalho
TGTania Mara Pinto Dabés Guimarães
Tania Mara Pinto Dabés Guimarães
MAMarcio Sobreira Silva Araújo
Marcio Sobreira Silva Araújo
RFRicardo Fujiwara
Ricardo Fujiwara
Leprosy remains a significant health concern, particularly in India, Brazil, and Indonesia. Early diagnosis is essential to prevent complications, highlighting the need for improved diagnostic tools. This study aimed to identify novel Mycobacterium leprae antigens and assess their effectiveness against human sera through immunotools for antibody response evaluation. Using bioinformatics, we predicted B-cell epitopes in M. leprae, which were chemically synthesized and tested via dot blotting with sera from leprosy patients, tuberculosis patients, and healthy controls. Promising peptides underwent further analysis through ELISA using 465 serum samples from leprosy patients, household contacts, and healthy controls across Brazil. The samples were also tested against known antigens HSA-NDO, LID-1, and NDO-LID. A total of 102 epitope sequences were generated, of which eight (PEP1 to PEP8) demonstrated the ability to differentiate between individuals with and without exposure to M. leprae. The results of the ELISA test exhibited statistically significant differences in absorbance responses between the experimental groups for the novel synthetic peptides (p < 0.05). PEP3, PEP4, and PEP5 demonstrated the most favorable outcomes, with values of the area under the receiver operating characteristic curve (AUC) of 0.9759, 0.9796 and 0.9551 respectively in the comparison of healthy controls with household contacts, and 0.8257, 0.7945, and 0.7961 comparing the same controls with patients. Furthermore, the synthetic peptides demonstrated superior sensitivity, specificity, and AUC compared to HSA-NDO, LID-1, and NDO-LID. The identified peptides showed significant responses in samples from patients and household contacts (HHC), indicating their potential for tracing exposure to M. leprae bacilli. These novel synthetic peptides could enhance the sensitivity of rapid diagnostic tests for leprosy, facilitating early detection of the infection. This could help prevent disease progression and interrupt transmission.